IP Library Granted Patent US 8,788,031
Granted Patent B2
US 8,788,031 · App. 11/586,818 · Granted Jul 22, 2014

Method and device for the iontophoretic delivery of a drug

Inventors: Gregory A. Fischer (Salt Lake City, UT); Malcolm E. Taylor (Pepperell, MA); Edward M. Kolvek (West Newbury, MA)
Assignee: Encore Medical Asset Corporation
View Patent ↗
Loading inventors, assignments & file history…
Monitor This Case
Get email alerts when status or documents change.
Order Certified Copies
Most orders are placed with the USPTO same day — all within 24 business hours.
Order via The Patent Place →
Pre-filled with this patent's details
Quick Facts
Patent No.
US 8,788,031
App. No.
11/586,818
Granted
Jul 22, 2014
Kind
B2
Abstract

An iontophoretic drug delivery device storage apparatus and a method of using that device is disclosed. The device comprises a fluid reservoir, an electrode assembly and a tray apparatus. The fluid reservoir is capable of retaining a medicament and has a sealed fluid chamber defined by at least one seal. The seal includes a weaker region and a pinch-like configuration associated with that region such that application of pressure to the fluid reservoir breaks the weaker region of the seal, releasing the retained medicament. The electrode assembly comprises an active electrode, at least two passive electrodes a medicament carrying region, and a moat region around the medicament carrying region so that once fluid is delivered from the fluid reservoir to the electrode assembly the fluid is substantially retained in the medicament carrying means.

Claims (33)

1. A method for iontophoretically administering a medicament to a patient using an electrode assembly, the method comprising the steps of:

releasing a fluid from a fluid reservoir into a medicament container associated with an electrode assembly;

separating the electrode assembly from the fluid reservoir by removing the electrode assembly from a tray assembly and retaining the fluid reservoir in the tray assembly;

applying the electrode assembly to a surface of a patient, wherein the electrode assembly comprises an active electrode configured to create an electric field between the active electrode and at least two passive electrodes, the step of applying comprising:

placing the active electrode on the surface of a patient spaced apart from the at least two passive electrodes, and

placing the at least two passive electrodes on the surface of a patient such that the passive electrodes are spaced apart from one another; and

applying an electrical potential that extends simultaneously across the active electrode, the surface of the skin, and the at least two passive electrodes, thereby driving the impregnated medicament from the container and into the skin.

2. The method according to claim 1 , wherein the step of placing the at least two passive electrodes comprises placing the at least two passive electrodes on opposite sides of the active electrode.

3. The method according to claim 1 , wherein the step of applying the electrode assembly additionally comprises the step of applying a migration prevention means to the surface, wherein the migration prevention means is spaced apart from the active electrode.

4. A method for iontophoretically applying a stored medicament to a patient, comprising:

removing a tray assembly from storage, the tray assembly comprising a substantially rigid shell, configured to hold a fluid reservoir and an electrode assembly in relative positions, and a removable cover;

applying force to a portion of the shell, associated with the fluid reservoir;

compressing at least a portion of the shell into a top surface of the fluid reservoir;

fracturing at least a portion of a first region of at least one seal of the fluid reservoir, while substantially maintaining the integrity of a second region of the at least one seal;

releasing a fluid from a cavity within the fluid reservoir;

directing the flow of a released fluid out of the cavity, and onto a medicament carrying surface of the electrode assembly;

separating the electrode assembly from the fluid reservoir by removing the electrode assembly from the tray assembly and retaining the fluid reservoir in the tray assembly;

applying the electrode assembly to a surface of a patient, wherein the step of applying further comprises:

placing an active electrode, in electrical communication with the medicament carrying surface, wherein the active electrode is spaced apart from at least two passive electrodes, and wherein the active electrode is configured to create an electric field simultaneously between the active electrode and the at least two passive electrodes, and

placing the at least two passive electrodes such that the passive electrodes are spaced apart from one another, wherein the active electrode and the at least two passive electrodes are coupled to an attachment surface; and

iontophoretically administering the fluid to a patient using the electrode assembly.

5. The method according to claim 3 , wherein the migration prevention means is spaced apart from the active electrode so as to form a moat-like region therebetween.

6. The method according to claim 3 , wherein the migration prevention means prevents medicament from migrating toward the at least two passive electrodes when the medicament is driven from the container and into the skin.

7. The method according to claim 3 , wherein the migration prevention means prevents electrical bleed through from the active electrode to the at least two passive electrodes when the electrical potential is applied.

8. The method according to claim 3 , wherein the migration prevention means includes a separator pad.

9. The method according to claim 3 , wherein a side of the migration prevention means applied to the surface includes an adhesive.

10. The method according to claim 4 , wherein the step of placing the at least two passive electrodes comprises placing the at least two passive electrodes on opposite sides of the active electrode.

11. The method according to claim 4 , wherein the step of applying the electrode assembly additionally comprises the step of applying a migration prevention means to the surface, wherein the migration prevention means is spaced apart from the active electrode.

12. The method according to claim 11 , wherein the migration prevention means is spaced apart from the active electrode so as to form a moat-like region therebetween.

13. The method according to claim 11 , wherein the migration prevention means prevents medicament from migrating toward the at least two passive electrodes when the medicament is driven from the container and into the skin.

14. The method according to claim 11 , wherein the migration prevention means prevents electrical bleed through from the active electrode to the at least two passive electrodes when the electrical potential is applied.

15. The method according to claim 11 , wherein the migration prevention means includes a separator pad.

16. The method according to claim 11 , wherein a side of the migration prevention means applied to the surface includes an adhesive.

Assignments (18)
SECURITY INTEREST Recorded Jan 3, 2024
From: DJO, LLC
To: JPMORGAN CHASE BANK, N.A., AS ADMINISTRATIVE AGENT
Reel/Frame 066186/0659 →
RELEASE OF SECURITY INTEREST Recorded Mar 21, 2019
From: WELLS FARGO BANK, NATIONAL ASSOCIATION AS COLLATERAL AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC
Reel/Frame 048672/0661 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: THE BANK OF NEW YORK MELLON AS THIRD LIEN AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC
Reel/Frame 048608/0932 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: THE BANK OF NEW YORK MELLON AS SECOND LIEN AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC
Reel/Frame 050129/0262 →
RELEASE OF SECURITY INTEREST Recorded Mar 14, 2019
From: MACQUARIE US TRADING LLC AS COLLATERAL AGENT
To: DJO, LLC; ENCORE MEDICAL, L.P.; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC
Reel/Frame 048655/0067 →
RELEASE BY SECURED PARTY Recorded Jan 16, 2019
From: BANK OF AMERICA, N.A.
To: REABLE THERAPEUTICS HOLDINGS LLC; REABLE THERAPEUTICS FINANCE LLC
Reel/Frame 048080/0952 →
RELEASE OF SECURITY INTEREST Recorded May 18, 2015
From: CREDIT SUISSE AG, AS COLLATERAL AGENT
To: DJO, LLC; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC
Reel/Frame 035706/0497 →
RELEASE OF SECURITY INTEREST Recorded May 18, 2015
From: THE BANK OF NEW YORK MELLON, AS SECOND LIEN AGENT
To: DJO, LLC; ENCORE MEDICAL ASSET CORPORATION; RIKCO INTERNATIONAL, LLC; EMPI, INC.
Reel/Frame 035706/0457 →
SECURITY AGREEMENT Recorded May 18, 2015
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; ENCORE MEDICAL, L.P.; RIKCO INTERNATIONAL, LLC
To: MACQUARIE US TRADING LLC, AS COLLATERAL AGENT
Reel/Frame 035707/0398 →
SECURITY AGREEMENT Recorded May 18, 2015
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; ENCORE MEDICAL, L.P.; RIKCO INTERNATIONAL, LLC
To: THE BANK OF NEW YORK MELLON, AS SECOND LIEN AGENT
Reel/Frame 035707/0454 →
SECURITY AGREEMENT Recorded May 18, 2015
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; ENCORE MEDICAL, L.P.; RIKCO INTERNATIONAL, LLC
To: THE BANK OF NEW YORK MELLON, AS THIRD LIEN AGENT
Reel/Frame 035707/0498 →
SECURITY INTEREST Recorded May 7, 2015
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; ENCORE MEDICAL, L.P.; RIKCO INTERNATIONAL, LLC
To: WELLS FARGO BANK, NATIONAL ASSOCIATION, AS THE COLLATERAL AGENT
Reel/Frame 035614/0001 →
CHANGE OF NAME Recorded Mar 24, 2014
From: IOMED, INC.
To: IOMED, LLC
Reel/Frame 032536/0225 →
SECURITY AGREEMENT Recorded Apr 20, 2012
From: DJO, LLC; EMPI, INC.; ENCORE MEDICAL ASSET CORPORATION; RICKO INTERNATIONAL, LLC
To: THE BANK OF NEW YORK MELLON, AS SECOND LIEN AGENT
Reel/Frame 028078/0320 →
SECURITY AGREEMENT Recorded Dec 13, 2007
From: ENCORE MEDICAL ASSET CORPORATION
To: CREDIT SUISSE, AS COLLATERAL AGENT
Reel/Frame 020234/0433 →
SECURITY AGREEMENT Recorded Nov 15, 2007
From: REABLE THERAPEUTICS HOLDINGS LLC; REABLE THERAPEUTICS FINANCE LLC
To: BANK OF AMERICA, N.A., AS COLLATERAL AGENT
Reel/Frame 020112/0579 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Sep 10, 2007
From: IOMED, LLC (F/K/A IOMED, INC.)
To: ENCORE MEDICAL ASSET CORORATION
Reel/Frame 019795/0561 →
ASSIGNMENT OF ASSIGNOR'S INTEREST Recorded Oct 25, 2006
From: FISCHER, GREGORY A.; TAYLOR, MALCOLM E.; KOLVEK, EDWARD M.
To: IOMED, INC.
Reel/Frame 018466/0907 →
Continuity (3)
Division 10054713 · Jan 22, 2002
Continuation 09960833 · Sep 21, 2001
Related Publication 20070100317A1 · May 3, 2007